Gliminyle MV 1mg/500mg/0.3mg Tablet
Marketer
Erinyle Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Gliminyle MV 1mg/500mg/0.3mg Tablet
This anti-diabetic medication, a combination drug classified as Gliminyle MV 1mg/500mg/0.3mg Tablet, is indicated for adult patients with type 2 diabetes mellitus. Its purpose is to regulate blood glucose. Administer this tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Gliminyle MV 1mg/500mg/0.3mg Tablet
Managing Type 2 Diabetes
Major Benefits of Gliminyle MV 1mg/500mg/0.3mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Gliminyle MV 1mg/500mg/0.3mg tablet on an empty stomach.
Common Side effects of Gliminyle MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Gliminyle MV 1mg/500mg/0.3mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Gliminyle MV 1mg/500mg/0.3mg tablets on an empty stomach.
How Gliminyle MV 1mg/500mg/0.3mg Tablet works:
One tablet of Gliminyle MV contains 1mg, 500mg, and 0.3mg of three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gliminyle MV 1mg/500mg/0.3mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Gliminyle MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Gliminyle MV 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Gliminyle MV 1mg/500mg/0.3mg tablets pose a likely risk for individuals with kidney disease and should be omitted. Medical advice is necessary. Furthermore, this medication is unsuitable for patients exhibiting severe kidney impairment.
LiverCAUTION
Patients with liver disease should use Gliminyle MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver impairment, a low initial dose is typically prescribed; however, the medication is contraindicated in patients with severe liver disease.
What if you forget to take Gliminyle MV 1mg/500mg/0.3mg Tablet :
Should you forget to take a Gliminyle MV 1mg/500mg/0.3mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Gliminyle MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently